Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

News From Vertex and Cassava: Two Prohost Portfolio Selected Biotech Firms

March 31, 2022 0

Vertex Pharmaceuticals Statistically Significant Results From Vertex VX-548 for Acute Pain Vertex Pharmaceuticals (VRTX) announced positive …

Our Most Pressing Need. See Also: Important, Recent News from Incyte & Eli Lilly and Halozyme

March 29, 2022 0

Our Most Pressing Need Our current, most pressing need is news that makes sense. Stock Market …

Comprehensive Prohost Letter #449 – Reality

March 27, 2022 0

Comprehensive Prohost Letter Issues Reality The Best of words in informative texts are the smallest in …

What Happened Over the Past Two Days and Biotech

March 10, 2022 0

Some Gains in Biotech Stocks During the War in Europe On Tuesday, Mar 8,2022 the United …

Intellia Therapeutics Statement on Recent U.S. Patent and Trademark Office Decision

March 4, 2022 0

Intellia Therapeutics Statement on Recent U.S. Patent and Trademark Office Decision – In May 2012, the …

These Dangerous World Circumstances and the Prohost Portfolio

March 4, 2022 0

The circumstances that we find the world in today are abnormal. They are extremely intense and …

What Happens to Intellia When the U.S. Patent and Trademark Office Changes Previous Patent Decisions?

March 1, 2022 0

Intellia Therapeutics Loses Technology Patent and Suffers a Selloff A selloff of Intellia Therapeutics (NTLA) stock …

Our Plan as the Stock Market Continues to Plummet

February 17, 2022 2

The Stock Market Continues to Plummet Indeed, the Stock Market continues to decline, losing investors' profits. …

Karyopharm Therapeutics Getting a Boost in the Midst of a Chaotic Market

February 14, 2022 0

We do not dare invest in the stock market at a time when almost all the …

Who Forgot About Enanta Pharmaceuticals?

February 11, 2022 0

Enanta Pharmaceuticals Expectations Expecting Dosing in a First-in-Human Study of EDP-235, an Oral 3CL Protease Inhibitor …

An Important Milestone for Regenxbio Treatment of Wet AMD

February 8, 2022 0

Regenxbio Good News for wet AMD On January 10, 2022, Regenxbio Inc. (RGNX) announced the initiation of …

Why Intellia Therapeutics Acquisition of Rewrite Therapeutics Is Important

February 7, 2022 0

Intellia Therapeutics Acquires Rewrite Therapeutics The acquisition is, indeed good news. By acquiring Rewrite Therapeutics, Intellia …

Some Ideas About the Falling Stock Market Day

February 3, 2022 0

The Stock Market Today Before the end of 2021 we recognized that investors were not going …

We Are Back

February 1, 2022 2

We Are Back! Thanks to God. Hello to all our subscribers. Our sickness was unanticipated, making …

Celularity Inc NK Cell Therapy CYNK-001 Receives US FDA Fast Track Designation for AML Treatment

December 28, 2021 0

Celularity Inc Celularity Inc. (CELU) announced the U.S. Food and Drug Administration (FDA) has granted Fast …

Important and Encouraging News from Sutro Biopharma Inc

December 27, 2021 0

Sutro Biopharma Inc and Tasly Biopharmaceuticals Exclusive Licensing Agreement for STRO-002 In a press release from …

The FDA Authorized Emergency Use of Pfizer Paxlovid Pills Against COVID-19

December 25, 2021 0

Pfizer Received Emergency Use Authorization from the FDA for Paxlovid Pills for COVID-19 Good news for …

Comprehensive Prohost Letter #448

December 22, 2021 0

Comprehensive Prohost Letter Issues Coronavirus Variant Omicron A lot has happened since the coronavirus variant Omicron …

Gilead Sciences and Arcus Biosciences: Complete Closing of Option Exercises of 3 Programs. See Also: HOLD Put on Lenacapavir Due to Vial Quality Concern